IP Library Granted Patent US 9,050,103
Granted Patent B2
US 9,050,103 · App. 13/426,887 · Granted Jun 9, 2015

System and method for endometrial ablation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,103
App. No.
13/426,887
Granted
Jun 9, 2015
Kind
B2
Abstract

A wall of a uterus is ablated by expanding a structure in the uterus and applying energy across the wall of the structure into the uterine wall. An exterior surface of the structure conforms to an inner wall of the uterus, and the energy may cause vapor to collect between the wall and the structure. The vapor is released by providing a barrier to release which is inflated at a pressure above which the barrier at least partially collapses to allow the vapor to leave the uterus.

Claims (23)

1. A method for ablating a wall of a uterus, said method comprising:

expanding a structure in the uterus, wherein an exterior surface of a wall of the structure conforms to an inner wall of the uterus;

applying energy from the structure into the uterine wall, wherein vapor is generated between the exterior surface and the inner wall; and

releasing the vapor from the uterine cavity when the vapor pressure exceeds a preselected level,

wherein releasing comprises providing a barrier that releases the vapor when the vapor pressure exceeds the preselected level.

2. A method as in claim 1 , wherein the preselected level is in the range from 10 mm Hg to 100 mm Hg.

3. A method as in claim 1 , wherein the preselected level is in the range from 25 mm Hg to 75 mm Hg.

4. A method as in claim 1 , wherein releasing includes inflating the barrier at an inflation pressure equal to the preselected level.

5. A method as in claim 4 , wherein the barrier comprises a balloon which is independent of the structure.

6. A method as in claim 5 , wherein the structure is inflated at a pressure independent of the barrier.

7. A method as in claim 4 , wherein the barrier comprises a portion of the structure, and the structure is inflated at the predetermined level.

8. A method as in claim 1 , wherein releasing comprises passing the vapor through a lumen of a probe which carries the structure.

9. An endometrial ablation device, said device comprising:

a probe having a proximal end, a distal end, and a lumen extending from the proximal and to the distal end;

a structure coupled to the distal end of the probe and expandable from a collapsed configuration to an expandable configuration which conforms to an inner wall of the uterus;

a barrier element disposed on the probe to control a flow of vapor from a uterine cavity into the probe lumen, wherein the element is deformable at a predetermined pressure above which flow occurs and below which flow is inhibited.

10. An endometrial ablation device as in claim 9 , wherein the barrier element is disposed in a distal end of the lumen.

11. An endometrial ablation device as in claim 10 , wherein the barrier element is a balloon structure which is inflatable independently of the expandable structure.

12. An endometrial ablation device as in claim 10 , wherein the barrier element comprises a proximal portion of the expandable structure.

13. An endometrial ablation device as in claim 9 , further comprising an inflation source coupled to deliver an inflation medium to the barrier element.

14. An endometrial ablation device as in claim 13 , wherein the inflation source is adapted to inflate the barrier element at a pressure in the range from 10 mm Hg to 100 mm Hg.

15. An endometrial ablation device as in claim 13 , wherein the inflation source is adapted to inflate the barrier element at a pressure in the range from 25 mm Hg to 75 mm Hg.

16. An endometrial ablation device as in claim 9 , wherein a distal end of the probe surrounds the barrier element and is slotted to permit expansion while protecting surrounding tissue.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2012
From: TRUCKAI, CSABA
To: MINERVA SURGICAL, INC.
Reel/Frame 028305/0832 →